Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy

Neurology

Volumn 54, Issue 11, 2000, Pages 2108-2114

  Swan, G E ^a   DeCarli, C ^b   Miller, B L ^c   Reed, T ^d   Wolf, P A ^e   Carmelli, D ^a  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

Aging; Atrophy; MRI; Neuropsychological function; White matter hyperintensities

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; COGNITIVE DEFECT; CORONARY RISK; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TASK PERFORMANCE;

EID: 0034643822     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.11.2108     Document Type: Article

References (52)

1. Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control: the ARIC Study. Stroke 1996;27:2262-2270.
2. Manolio TA, Kronmal RA, Burke GL, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke 1994;25:318-327.
3. Salerno JA, Murphy DGM, Horwitz B, et al. Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension 1992;20:340-348.
4. Schochet SS. Neuropathology of aging. Neurol Clin North Am 1998;16:569-580.
5. DeCarli C, Murphy DGM, Tran M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism in 51 healthy adults. Neurology 1995;45:2077-2084.
6. Carmelli D, Swan GE, Reed T, et al. Midlife cardiovascular risk factors, apo E, and cognitive decline in elderly male twins. Neurology 1998;50:1580-1585.
7. DeCarli C, Miller BL, Swan GE, et al. Predictors of brain morphology for the men of the NHLBI Twin Study. Stroke 1999;30:529-536.
8. Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998;51:986-993.
9. Feinleib M, Garrison RJ, Fabsitz RR, et al. The NHLBI Twin Study of cardiovascular risk factors: methodology and summary of results. Am J Epidemiol 1977;106:284-295.
10. Jablon S, Neel JV, Gershowitz H, Atkinson GF. The NAS/NRC twin panel: methods of construction of the panel, zygosity diagnosis, and proposed use. Am J Hum Genet 1967;19:133-161.
11. Radloff LW. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Measure 1977;1:385-401.
12. Yesavage JA. The use of self-rating depression scales in the elderly. In: Poon LW, ed. Handbook for clinical memory assessment of older adults. Washington, DC: American Psychological Association, 1986:213-217.
13. Swan GE, Carmelli D. Curiosity and mortality in aging adults: A 5-year follow-up of the Western Collaborative Group Study. Psychol Aging 1996;11:449-453.
14. Spielberger CD. Preliminary manual for the State-Trait Personality Inventory. Tampa, FL: University of South Florida, Human Resources Institute, 1979.
15. Kirkendall WM, Feinleib M, Fires ED, Mark AL. Recommendations for human blood pressure determination by sphygmomanometers: Subcommittee of the AHA Postgraduate Education Committee. Circulation 1980;62:1146A-1155A.
16. Lee M-LT, Rosner BA, Vokonas PS, Weiss ST. Longitudinal analysis of adult male blood pressure: the Normative Aging Study, 1963-1992. J Epidemiol Biostat 1996;1:79-87.
17. Tate RB, Manfreda J, Krahn AD, Cuddy TE. Tracking of blood pressure over a 40-year period in the University of Manitoba Follow-up Study. 1948-1988. Am J Epidemiol 1995;142:946-954.
18. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997;96:308-315.
19. Lee M-LT, Rosner BA, Weiss ST. Relationship of blood pressure to cardiovascular death: the effects of pulse pressure in the elderly. Ann Epidemiol 1999;9:101-107.
20. Rogosa DR, Brandt D, Zimowski M. A growth curve approach to the measurement of change. Psychol Bull 1982;92:726-748.
21. Reed T, Quiroga J, Selby JV, et al. Concordance of ischemic heart disease in the NHLBI Twin Study after 14-18 years of follow-up. J Clin Epidemiol 1991;44:795-805.
22. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993;270:487-489.
23. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-548.
24. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
25. Feskens EJM, Havekes LM, Kalmijn S, de Kniff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 1994;309:1202-1206.
26. O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM Jr. The apoE epsilon 4 allele is associated with decline on delayed recall performance in community dwelling older adults. J Am Geriatr Soc 1998;46:1493-1498.
27. Schuit AJ, Schouten EG, Westerterp KR, Saris WH. Validity of the Physical Activity Scale for the Elderly (PASE): according to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol 1997;50:541-546.
28. Benton AL. Revised Visual Retention Test. 4th ed. New York: Psychological Corporation, 1974.
29. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. New York: Psychological Corporation, 1987.
30. Eslinger PJ, Damasio AR, Benton AL, Van Allen M. Neuropsychologic detection of abnormal mental decline in older persons. JAMA 1985;253:670-674.
31. Wechsler D. Manual. Wechsler Adult Intelligence Scale-revised. New York: Psychological Corporation, 1974.
32. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for clinicians. J Psychiatr Res 1975;12:189-198.
33. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
34. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
35. SAS Institute, Inc. SAS/STAT guide. Version 6. Cary, NC: SAS Institute, 1987.
36. Aldoori MI, Rahman SH. Smoking and stroke: a causative role. BMJ 1998;317:762-763.
37. Colditz GA, Bonita R, Stampfer MJ, et al. Cigarette smoking and risk of stroke in middle aged women. N Engl J Med 1988;18:937-941.
38. Molgaard CA, Bartok A, Peddecord KM, Rothrock J. The association between cerebrovascular disease and smoking: a case-control study. Neuroepidemiology 1986;5:88-94.
39. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988;259:1025-1029.
40. Longstreth WT, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people. Arch Neurol 1998;55:1217-1225.
41. Cruickshank JM, Neil-Dwyer G, Dorrance DE, Hayes Y, Patel S. Acute effects of smoking on blood pressure and cerebral blood flow. J Hum Hypertens 1989;3:443-449.
42. Fitzgerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988;115:267-271.
43. Crouse JR, Toole JF, McKinney WM, et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987;18: 990-996.
44. Ring T, Kristensen SD, Jensen PN, Mourits-Anderson T, Madsen H, Dyerberg J. Cigarette smoking shortens the bleeding time. Thromb Res 1983;32:531-536.
45. Silvestrini M, Troisi E, Matteis M, Cupini LM, Bernardi G. Effect of smoking on cerebrovascular reactivity. J Cereb Blood Flow Metab 1996;16:746-749.
46. Rogers RL, Meyer JS, Judd BW, Mortel KF. Abstention from cigarette smoking improves cerebral perfusion among elderly chronic smokers. JAMA 1985;253:2970-2974.
47. Franklin SS, Sutton-Tyrrell K, Belle SH, Weber MA, Kuller LH. The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults. J Hypertens 1997;15:1143-1150.
48. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999;100:354-360.
49. DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D. Impact of apolipoprotein E ∈4 and vascular disease on brain morphology in men from the NHLBI Twin Study. Stroke 1999; 30:1548-1553.
50. Royall DR, Mahurin RK. Neuroanatomy, measurement, and clinical significance of the executive cognitive functions. In: Dickstein LJ, Oldham JM, Riba MB, eds. Review of psychiatry. Vol. 15. Washington, DC: American Psychiatric Press, 1995:175-204.
51. Luria AR. Frontal lobe syndromes. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Vol. 2. Amsterdam: North Holland, 1969:725-757.
52. Fogel BS. The significance of frontal system disorders for medical practice and health policy. J Neuropsychiatry Clin Neurosci 1994;6:343-347.